Publication | Open Access

Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: Correlation with induction of increased levels of intracellular interkukin-2 in peripheral blood lymphocytes

Cancer ImmunosurveillanceSrl 172Peripheral Blood LymphocytesMedicineMelanomaImmunologyImmune Checkpoint InhibitorIntracellular Interkukin-2ImmunotherapyOncologyRadiation OncologySkin Cancer